all the information, none of the junk | biotech • healthcare • life sciences

Nano Terra Acquires Surface Logix

Xconomy Boston — 

Nano Terra, a Brighton, MA-based company that works with industry on surface engineering and nanotechnology projects, said today that it has acquired the drug developer Surface Logix. The terms and details of the deal were not disclosed. Harvard University chemist George Whitesides (an Xconomist) is a founder of both Nano Terra and Surface Logix. “Surface Logix is an excellent fit for Nano Terra since our business was also built on intellectual property from the Whitesides lab,” said Myer Berlow, CEO of Nano Terra, in a statement. “We think we can achieve significant synergies through our proven co-development model. This acquisition opens the door to the use of Nano Terra’s technology in a variety of healthcare products.”